Also known as: Critical Mass CBD (CBD-rich phenotype) · Critical (shortened)

Critical Mass

High-yielding indica-dominant hybrid known for dense buds and bud rot susceptibility.

Automated fact-check pass
7 cited sources
Published
Last reviewed
How this page was made

Growing, buying or possessing cannabis and seeds is legal only in some places. Check the law where you live before acting on this information.

↯ The honest take

Critical Mass earned its reputation for yield, not for being uniquely potent or sedating. It's genuinely productive, but the dense buds are a liability in humid climates—expect bud rot unless you're aggressive with dehumidification. The lineage (Big Bud × Skunk #1) comes from Mr. Nice, but dozens of seedbanks now sell their own 'Critical Mass' with no genetic link. Treat the name as a loose category, not a guarantee.

Overview

Critical Mass is an indica-dominant hybrid most often credited to Shantibaba's Mr. Nice Seedbank, who describes it as a cross of Big Bud and Skunk #1 [1]. It became popular in European seed catalogs in the early 2000s and remains a commercial and home-garden staple, primarily because of one trait: yield. The dense, heavy buds often require physical support during late flowering.

The name 'Critical Mass' is now used by multiple seed companies for genetics that may or may not trace back to the Mr. Nice line. A separate CBD-rich version—sometimes labeled 'Critical Mass CBD' or 'CBD Critical Mass'—is offered by breeders such as Dinafem and CBD Crew [2]. Treat the strain name as a category rather than a guarantee of identical genetics across vendors. Without genetic testing, you cannot verify whether two 'Critical Mass' samples are actually the same line.

Chemistry

Cannabinoids. Standard Critical Mass typically tests in the 19–22% THC range with negligible CBD, based on commercial lab reports and seedbank figures [1][2]. CBD-rich phenotypes marketed under the same name commonly report roughly 1:1 THC:CBD ratios, with both cannabinoids in the 5–8% range [2]. Individual plant chemistry varies substantially with phenotype, cultivation, and harvest timing — strain-name THC averages should be read as rough guidelines, not specifications Strong evidence[3].

Terpenes. Published terpene profiling of cultivars sold as Critical Mass is sparse in peer-reviewed literature. Available commercial lab reports and aggregated lab datasets consistently list myrcene as the dominant terpene, with secondary contributions from caryophyllene and pinene Weak / limited[4]. This is a common myrcene-dominant profile shared with many indica-labeled cultivars.

A note on the myrcene myth: The often-repeated claim that 'myrcene above 0.5% makes a strain sedating' originated in popular cannabis writing and has been repeated until it sounds like fact. It is not supported by controlled human research Disputed. See The Myrcene 0.5% Threshold for details.

Reported effects

There is no strain-specific clinical research on Critical Mass. Everything below is aggregated user reporting from consumer platforms and seedbank descriptions, which are subject to expectancy effects, selection bias, and marketing influence Anecdote.

Commonly reported effects:

Users report it for muscle tension, insomnia, and appetite loss Anecdote. These reports align with what is known about THC pharmacology generally—but they are not evidence that this specific cultivar outperforms others for those uses.

The 'indica = sedating, sativa = energizing' framework that drives most strain marketing has been repeatedly challenged in chemotaxonomic studies, which find that indica/sativa labels poorly predict chemistry or effect Strong evidence[5]. See The Indica/Sativa Myth for a full breakdown.

Lineage and breeding

The widely cited lineage for the original Mr. Nice line is Big Bud × Skunk #1 [1]. Shantibaba has stated the line was developed to recover and stabilize the yield traits of older Big Bud stock he worked with in the 1990s.

Important caveats:

Treat any specific lineage claim on a seed packet as a marketing assertion unless backed by genotype data.

Cultivation

Critical Mass is popular with growers for its speed and yield, but those same traits create its main cultivation challenge: bud rot.

Flowering time: ~7–8 weeks indoors; outdoor harvest in the Northern Hemisphere typically occurs in mid- to late September [1].

Yield: Reported indoor yields commonly land in the 500–600 g/m² range under competent cultivation, with outdoor plants capable of producing well over 600 g per plant in favorable conditions [1]. These are grower and breeder figures, not independently audited.

Plant structure: Short to medium height, with thick main colas and dense internodal flower clusters. Branches frequently need staking or netting in late flower to support the weight of buds.

**The main problem — bud rot (Botrytis cinerea):** Critical Mass is notoriously susceptible to gray mold because the dense bud structure traps humidity inside the flower Strong evidence[6]. This is the leading cause of late-flower crop loss for indoor growers.

Practical mitigations:

Difficulty rating: Easy to grow, harder to grow well. New growers often produce large plants and then lose 20–40% of the harvest to rot in the final two weeks.

Marketing vs. reality

Claim: 'Critical Mass is one of the highest-yielding strains in the world.' Reality: It is genuinely high-yielding for an indoor commercial cultivar, and that reputation is earned. But 'highest in the world' is a marketing flourish. Many modern hybrids match or exceed it under optimized conditions Weak / limited.

Claim: 'Heavy indica—guaranteed couch-lock.' Reality: Effect depends on dose, individual physiology, tolerance, set/setting, and the specific chemotype you're holding. Indica labeling does not reliably predict outcome Strong evidence[5].

Claim: 'Critical Mass CBD = the medical version.' Reality: A higher-CBD chemovar is a legitimate option for users who want less intoxication, but 'medical' is a regulatory and clinical designation, not a strain property. Strain-specific medical claims do not have clinical trial support No data.

Claim: 'Same genetics across every seedbank selling Critical Mass.' Reality: Almost certainly not. Without genotype data, assume each vendor's 'Critical Mass' is its own line Disputed.

Frequently asked questions

Is Critical Mass an indica or sativa? Critical Mass is marketed as an indica-dominant hybrid. However, 'indica' and 'sativa' are botanical classifications that do not reliably predict effects or chemistry. See The Indica/Sativa Myth for why these terms are misleading.

What is the typical THC level? Standard Critical Mass typically tests in the 19–22% THC range. CBD phenotypes report roughly 5–8% each of THC and CBD. These are averages from seedbank and lab reports; individual samples vary. Check a Certificate of Analysis (COA) from your source for actual numbers.

How long is the flowering time? Critical Mass flowers in approximately 7–8 weeks indoors. Outdoor harvest in the Northern Hemisphere typically occurs in mid- to late September.

Who actually bred Critical Mass? The most widely cited breeder is Shantibaba of Mr. Nice Seedbank, who describes the line as Big Bud × Skunk #1. However, many seed companies now sell a 'Critical Mass' with unclear or unverified lineage. Without genetic testing, you cannot confirm whether a seed packet's 'Critical Mass' is actually from Mr. Nice or a separate line.

Sources

How this page was made

Generation history

Oct 30, 2026
Fact-check pass — raised 8 flags
Oct 30, 2026
Revision
May 11, 2026
Fact-check pass — raised 3 flags
May 11, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.